HPI works with stakeholders to research and define structural challenges to health care delivery and financing systems that impact on system performance and sustainability, analyze numbers, model assumptions and support with the definition of evidence-based, integrated solutions that address structural gaps. Since 2017, the HPI has established the Health Reforms Observatory, which surveys on a rolling basis general public awareness…
HPI deploys highly specialized teams to help address current pharmaceutical reimbursement challenges including: HTA dossier preparation Cost effectiveness analysis (CEA) models and technical reports Budget impact analysis (BIA) models and technical reports Epidemiological studies Cost of illness studies Systematic Literature Reviews (SLRs) for comparative analysis
HPI designs and supports with the implementation of integrated strategic marketing projects, including with strategic product launch, with an emphasis in therapeutic areas where a multi-disciplinary approach to product launch is required. Services in this area may include population and patient surveys, definition and quantification of evidence-based public health unmet need, definition and validation of launch key value drivers, research…
In line with our strategic goal, HPI has a track record of working with and through patient organisations to research, model and present evidence on patient access to care, patient quality of life, patient preferences and patient participation in health policy decision making.